PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1724624-0	1991	Ruthenium-red inhibits CGRP release by capsaicin and resiniferatoxin but not by ouabain, bradykinin or nicotine in guinea-pig heart: correlation with effects on cardiac contractility.	Ruthenium Red	0-13	calcitonin related polypeptide alpha	Homo sapiens	23-27	
15155534-5	2004	Moreover, WIN-2-evoked CGRP release was attenuated by the nonselective cation channel blocker ruthenium red but not by the vanilloid receptor type 1 (TRPV1) antagonist capsazepine, suggesting that, unlike certain endogenous and synthetic cannabinoids, WIN-2 is not a TRPV1 agonist but rather acts at an as yet unidentified cation channel.	Ruthenium Red	94-107	calcitonin related polypeptide alpha	Homo sapiens	23-27	
9103504-6	1997	In the isolated right and left guinea pig atria, GLNVA (0.01-10 microM) produced concentration-dependent positive inotropic and chronotropic effects, but these effects were inhibited by pretreatments with ruthenium red (1.0 microM), capsazepine (10 microM), human calcitonin-gene-related peptide (CGRP(8-37)) (1.0 microM) and sensory neuron denervation, respectively.	Ruthenium Red	205-218	calcitonin related polypeptide alpha	Homo sapiens	297-301	
1707713-20	1991	Ruthenium red inhibits capsaicin-induced CGRP-LI release and functional effects and may thus serve as an experimental tool in evaluating the function of capsaicin-evoked stimulation of peripheral nerve terminals.	Ruthenium Red	0-13	calcitonin related polypeptide alpha	Homo sapiens	41-45	
1718773-8	1991	The capsaicin-induced relaxation was reproducible and it was concentration dependently inhibited by ruthenium red which suggests that capsaicin releases CGRP in the arterial wall.	Ruthenium Red	100-113	calcitonin related polypeptide alpha	Homo sapiens	153-157